SCHEMBL7917569

SCHEMBL7917569

FC(F)(F)c1ccc(C(=CCBr)c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.53
PTPN1 P18031 2/20 0.53
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
SRD5A2 P31213 2/20 0.41
NR4A1 P22736 1/20 0.41
NR4A2 P43354 1/20 0.41
NR4A3 Q92570 1/20 0.41
PTGS1 P23219 2/20 0.39
MMP1 P03956 1/20 0.39
NQO2 P16083 1/20 0.39
PTGS2 P35354 1/20 0.39
PAX8 Q06710 1/20 0.39
ORAI1 Q96D31 1/20 0.38
ORAI2 Q96SN7 1/20 0.38
ORAI3 Q9BRQ5 1/20 0.38
TRPV6 Q9H1D0 1/20 0.38
KIF11 P52732 1/20 0.38
CYP1A1 P04798 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29055528 0.81 GSK3B (0.55) GSK3BPTPN1CES2CES1SRD5A2
SCHEMBL1746518 0.78 GSK3B (0.43) GSK3BPTPN1CES2CES1SRD5A2
SCHEMBL1746517 0.78 GSK3B (0.43) GSK3BPTPN1CES2CES1SRD5A2
SCHEMBL1746513 0.78 GSK3B (0.43) GSK3BPTPN1CES2CES1SRD5A2
SCHEMBL7925187 0.78 CES2 (0.49) CES2SRD5A2MAOB
SCHEMBL7925191 0.78 CES2 (0.49) CES2SRD5A2MAOB
SCHEMBL9377885 0.77 PTPN1 (0.48) PTPN1CES2CES1PTGS2MAOB
SCHEMBL3946752 0.76 CYP1A1 (0.45) GSK3BPTPN1CES2CES1SRD5A2
SCHEMBL3946748 0.76 CYP1A1 (0.45) GSK3BPTPN1CES2CES1SRD5A2
SCHEMBL1745106 0.74 TRPV1 (0.49) GSK3BPTPN1CES2CES1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174898-B1 TREATING FILARIAE IN LYMPHATIC SYSTEM BY ADMINISTERING N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS IN WHICH A SUBSTITUTED ALKYL CHAIN FORMS PART OF N-SUBSTITUENT AND SALTS NOVO NORDISK A/S (DK) 2001-01-16 US disclosed
EP-0502031-B1 N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND A PHARMACEUTICAL COMPOSITION NOVO NORDISK AS (DK) 1997-08-20 EP disclosed
US-5198451-A Treatment of epilepsy, inhibitors of gamma-aminobutyric acid uptake from synaptic cleft NOVO NORDISK A/S (DK) 1993-03-30 US disclosed
EP-0502031-A1 N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND A PHARMACEUTICAL COMPOSITION. NOVO NORDISK AS (DK) 1992-09-09 EP disclosed
WO-1991007389-A1 N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND A PHARMACEUTICAL COMPOSITION NOVO NORDISK A/S (DK) 1991-05-30 WO disclosed